Clinical trials and product development
- Hodgson SH, Llewellyn D, Silk SE, Milne KH, Elias SC, Miura K, Kamuyu G, Juma EA, Magiri C, Muia A, Jin J, Spencer AJ, Longley RJ, Mercier T, Decosterd L, Long CA, Osier FH, Hoffman SL, Ogutu B, Hill AV, Marsh K, Draper SJ. Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection. Front Microbiol. 2016 Oct 13;7:1604.
- Hodgson SH, Juma E, Salim A, Magiri C, Njenga D, Molyneux S, Njuguna P,Awuondo K, Lowe B, Billingsley PF, Cole AO, Ogwang C, Osier F, Chilengi R,Hoffman SL, Draper SJ, Ogutu B, Marsh K. Lessons learnt from the first controlledhuman malaria infection study conducted in Nairobi, Kenya. Malar J. 2015 Apr 28;14:182. doi: 10.1186/s12936-015-0671.. READ MORE
- Hodgson SH, Douglas AD, Edwards NJ, Kimani D, Elias SC, Chang M, Daza G,Seilie AM, Magiri C, Muia A, Juma EA, Cole AO, Rampling TW, Anagnostou NA, Gilbert SC, Hoffman SL, Draper SJ, Bejon P, Ogutu B, Marsh K, Hill AV, Murphy SC. Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies. Malar J. 2015 Jan 28;14:33. doi: 10.1186/s12936-015-0541-6.
- Hodgson SH, Juma E, Salim A, Magiri C, Kimani D, Njenga D, Muia A, Cole AO,Ogwang C, Awuondo K, Lowe B, Munene M, Billingsley PF, James ER, Gunasekera A,Sim BK, Njuguna P, Rampling TW, Richman A, Abebe Y, Kamuyu G, Muthui M, Elias SC,Molyneux S, Gerry S, Macharia A, Williams TN, Bull PC, Hill AV, Osier FH, Draper SJ, Bejon P, Hoffman SL, Ogutu B, Marsh K. Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection. Front Microbiol. 2014 Dec 12;5:686. doi: 10.3389/fmicb.2014.00686.